| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | fatty acid binding | 2.89e-07 | 69 | 41 | 5 | GO:0005504 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 3.02e-07 | 28 | 41 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 7.65e-07 | 35 | 41 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.58e-06 | 107 | 41 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | retinoid binding | 2.79e-06 | 48 | 41 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 3.03e-06 | 49 | 41 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 1.01e-05 | 66 | 41 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate kinase activity | 1.04e-05 | 21 | 41 | 3 | GO:0004550 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, phosphate group as acceptor | 8.11e-05 | 41 | 41 | 3 | GO:0016776 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound kinase activity | 1.22e-04 | 47 | 41 | 3 | GO:0019205 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.24e-04 | 239 | 41 | 5 | GO:0031406 | |
| GeneOntologyMolecularFunction | steroid binding | 1.57e-04 | 133 | 41 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.65e-04 | 254 | 41 | 5 | GO:0043177 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 2.69e-04 | 153 | 41 | 4 | GO:0008194 | |
| GeneOntologyMolecularFunction | intermediate filament binding | 4.25e-04 | 15 | 41 | 2 | GO:0019215 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 9.03e-04 | 211 | 41 | 4 | GO:0016758 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 2.82e-03 | 288 | 41 | 4 | GO:0016757 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing N-glycosyl compounds | 3.21e-03 | 41 | 41 | 2 | GO:0016799 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 4.38e-03 | 161 | 41 | 3 | GO:0051087 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 4.73e-03 | 50 | 41 | 2 | GO:0003755 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.18e-03 | 171 | 41 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 5.27e-03 | 172 | 41 | 3 | GO:0044325 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 5.30e-03 | 53 | 41 | 2 | GO:0016859 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 6.02e-03 | 815 | 41 | 6 | GO:0042803 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 6.05e-11 | 5 | 40 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 1.81e-10 | 6 | 40 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 1.81e-10 | 6 | 40 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.81e-10 | 6 | 40 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 2.52e-09 | 10 | 40 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 2.52e-09 | 10 | 40 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 8.56e-09 | 13 | 40 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 6.74e-08 | 5 | 40 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 7.08e-08 | 21 | 40 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 7.08e-08 | 21 | 40 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.76e-07 | 26 | 40 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.76e-07 | 26 | 40 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 5.39e-07 | 34 | 40 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound metabolic process | 9.20e-07 | 92 | 40 | 5 | GO:0072527 | |
| GeneOntologyBiologicalProcess | UTP biosynthetic process | 1.10e-06 | 11 | 40 | 3 | GO:0006228 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.47e-06 | 12 | 40 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | UTP metabolic process | 1.91e-06 | 13 | 40 | 3 | GO:0046051 | |
| GeneOntologyBiologicalProcess | GTP biosynthetic process | 1.91e-06 | 13 | 40 | 3 | GO:0006183 | |
| GeneOntologyBiologicalProcess | CTP biosynthetic process | 3.02e-06 | 15 | 40 | 3 | GO:0006241 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 3.07e-06 | 52 | 40 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside triphosphate biosynthetic process | 3.72e-06 | 16 | 40 | 3 | GO:0009209 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide metabolic process | 3.85e-06 | 55 | 40 | 4 | GO:0006220 | |
| GeneOntologyBiologicalProcess | CTP metabolic process | 4.51e-06 | 17 | 40 | 3 | GO:0046036 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside triphosphate metabolic process | 6.41e-06 | 19 | 40 | 3 | GO:0009208 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside triphosphate biosynthetic process | 7.53e-06 | 20 | 40 | 3 | GO:0009148 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 7.55e-06 | 141 | 40 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 8.51e-06 | 67 | 40 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide biosynthetic process | 1.51e-05 | 25 | 40 | 3 | GO:0009220 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside triphosphate metabolic process | 1.51e-05 | 25 | 40 | 3 | GO:0009147 | |
| GeneOntologyBiologicalProcess | GTP metabolic process | 2.38e-05 | 29 | 40 | 3 | GO:0046039 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 2.63e-05 | 89 | 40 | 4 | GO:0001523 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleotide metabolic process | 2.65e-05 | 30 | 40 | 3 | GO:0009219 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 3.26e-05 | 94 | 40 | 4 | GO:0042440 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 3.26e-05 | 94 | 40 | 4 | GO:0016101 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide biosynthetic process | 3.54e-05 | 33 | 40 | 3 | GO:0006221 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide metabolic process | 3.88e-05 | 34 | 40 | 3 | GO:0009218 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 5.03e-05 | 105 | 40 | 4 | GO:0006721 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 6.35e-05 | 40 | 40 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 6.68e-05 | 222 | 40 | 5 | GO:0071466 | |
| GeneOntologyBiologicalProcess | dTMP biosynthetic process | 7.65e-05 | 7 | 40 | 2 | GO:0006231 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleoside monophosphate biosynthetic process | 7.65e-05 | 7 | 40 | 2 | GO:0009177 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound biosynthetic process | 7.90e-05 | 43 | 40 | 3 | GO:0072528 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 8.02e-05 | 376 | 40 | 6 | GO:0008202 | |
| GeneOntologyBiologicalProcess | protein maturation by protein folding | 1.31e-04 | 9 | 40 | 2 | GO:0022417 | |
| GeneOntologyBiologicalProcess | 2'-deoxyribonucleotide metabolic process | 1.65e-04 | 55 | 40 | 3 | GO:0009394 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 1.71e-04 | 144 | 40 | 4 | GO:0006720 | |
| GeneOntologyBiologicalProcess | deoxyribose phosphate metabolic process | 1.74e-04 | 56 | 40 | 3 | GO:0019692 | |
| GeneOntologyBiologicalProcess | deoxyribonucleotide metabolic process | 1.84e-04 | 57 | 40 | 3 | GO:0009262 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleotide biosynthetic process | 1.99e-04 | 11 | 40 | 2 | GO:0009221 | |
| GeneOntologyBiologicalProcess | deoxyribonucleoside monophosphate biosynthetic process | 2.39e-04 | 12 | 40 | 2 | GO:0009157 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 3.07e-04 | 684 | 40 | 7 | GO:0010817 | |
| GeneOntologyBiologicalProcess | dTMP metabolic process | 3.29e-04 | 14 | 40 | 2 | GO:0046073 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | 4.58e-04 | 731 | 40 | 7 | GO:0032787 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 4.86e-04 | 525 | 40 | 6 | GO:0009410 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleoside monophosphate metabolic process | 4.90e-04 | 17 | 40 | 2 | GO:0009176 | |
| GeneOntologyBiologicalProcess | 2'-deoxyribonucleotide biosynthetic process | 6.14e-04 | 19 | 40 | 2 | GO:0009265 | |
| GeneOntologyBiologicalProcess | deoxyribonucleotide biosynthetic process | 6.14e-04 | 19 | 40 | 2 | GO:0009263 | |
| GeneOntologyBiologicalProcess | deoxyribose phosphate biosynthetic process | 6.14e-04 | 19 | 40 | 2 | GO:0046385 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside monophosphate biosynthetic process | 6.14e-04 | 19 | 40 | 2 | GO:0009130 | |
| GeneOntologyBiologicalProcess | liver development | 6.19e-04 | 202 | 40 | 4 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 6.54e-04 | 205 | 40 | 4 | GO:0061008 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 8.20e-04 | 382 | 40 | 5 | GO:0016042 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide biosynthetic process | 1.04e-03 | 232 | 40 | 4 | GO:0009152 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside monophosphate metabolic process | 1.16e-03 | 26 | 40 | 2 | GO:0009129 | |
| GeneOntologyBiologicalProcess | ribonucleotide biosynthetic process | 1.31e-03 | 247 | 40 | 4 | GO:0009260 | |
| GeneOntologyBiologicalProcess | ribose phosphate biosynthetic process | 1.43e-03 | 253 | 40 | 4 | GO:0046390 | |
| GeneOntologyBiologicalProcess | neuron development | 1.63e-03 | 1463 | 40 | 9 | GO:0048666 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside triphosphate biosynthetic process | 1.78e-03 | 124 | 40 | 3 | GO:0009206 | |
| GeneOntologyBiologicalProcess | purine nucleoside triphosphate biosynthetic process | 1.82e-03 | 125 | 40 | 3 | GO:0009145 | |
| GeneOntologyBiologicalProcess | deoxyribonucleoside monophosphate metabolic process | 1.86e-03 | 33 | 40 | 2 | GO:0009162 | |
| GeneOntologyBiologicalProcess | ribonucleoside triphosphate biosynthetic process | 2.04e-03 | 130 | 40 | 3 | GO:0009201 | |
| GeneOntologyBiologicalProcess | purine nucleotide biosynthetic process | 2.07e-03 | 280 | 40 | 4 | GO:0006164 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 2.23e-03 | 286 | 40 | 4 | GO:0042445 | |
| GeneOntologyBiologicalProcess | purine-containing compound biosynthetic process | 2.29e-03 | 288 | 40 | 4 | GO:0072522 | |
| GeneOntologyBiologicalProcess | nucleoside triphosphate biosynthetic process | 2.37e-03 | 137 | 40 | 3 | GO:0009142 | |
| GeneOntologyBiologicalProcess | metal ion transport | 2.83e-03 | 1000 | 40 | 7 | GO:0030001 | |
| GeneOntologyBiologicalProcess | regulation of T cell cytokine production | 2.87e-03 | 41 | 40 | 2 | GO:0002724 | |
| GeneOntologyBiologicalProcess | nucleotide biosynthetic process | 3.31e-03 | 319 | 40 | 4 | GO:0009165 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate biosynthetic process | 3.35e-03 | 320 | 40 | 4 | GO:1901293 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | 3.38e-03 | 767 | 40 | 6 | GO:0055086 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | 3.42e-03 | 1035 | 40 | 7 | GO:0019752 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide hormone secretion | 3.48e-03 | 157 | 40 | 3 | GO:0090277 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound catabolic process | 3.60e-03 | 46 | 40 | 2 | GO:0072529 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide secretion | 3.73e-03 | 161 | 40 | 3 | GO:0002793 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | 3.86e-03 | 1058 | 40 | 7 | GO:0043436 | |
| Domain | UDPGT | 1.05e-07 | 21 | 40 | 4 | PS00375 | |
| Domain | UDPGT | 1.05e-07 | 21 | 40 | 4 | PF00201 | |
| Domain | UDP_glucos_trans | 1.05e-07 | 21 | 40 | 4 | IPR002213 | |
| Domain | NDP_KINASES | 7.58e-07 | 9 | 40 | 3 | PS00469 | |
| Domain | NDK | 1.08e-06 | 10 | 40 | 3 | SM00562 | |
| Domain | NDK | 1.08e-06 | 10 | 40 | 3 | PF00334 | |
| Domain | Nucleoside_diP_kinase | 1.98e-06 | 12 | 40 | 3 | IPR001564 | |
| Domain | Nucleoside_diP_kinase_AS | 4.45e-05 | 5 | 40 | 2 | IPR023005 | |
| Domain | Kelch_2 | 3.44e-04 | 13 | 40 | 2 | IPR011498 | |
| Domain | Kelch_2 | 3.44e-04 | 13 | 40 | 2 | PF07646 | |
| Domain | FKBP_C | 5.27e-04 | 16 | 40 | 2 | PF00254 | |
| Domain | FKBP_PPIASE | 5.27e-04 | 16 | 40 | 2 | PS50059 | |
| Domain | PPIase_FKBP_dom | 8.29e-04 | 20 | 40 | 2 | IPR001179 | |
| Domain | - | 4.74e-03 | 48 | 40 | 2 | 2.120.10.80 | |
| Domain | Kelch-typ_b-propeller | 6.18e-03 | 55 | 40 | 2 | IPR015915 | |
| Domain | VWA | 6.40e-03 | 56 | 40 | 2 | PF00092 | |
| Pathway | REACTOME_DRUG_ADME | 1.43e-07 | 109 | 32 | 6 | M45012 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.55e-07 | 22 | 32 | 4 | MM15888 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.25e-07 | 24 | 32 | 4 | MM14599 | |
| Pathway | REACTOME_DRUG_ADME | 2.41e-07 | 119 | 32 | 6 | MM15692 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.67e-07 | 25 | 32 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 2.67e-07 | 25 | 32 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 2.67e-07 | 25 | 32 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 3.16e-07 | 26 | 32 | 4 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 4.31e-07 | 28 | 32 | 4 | M19580 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.70e-06 | 39 | 32 | 4 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.09e-06 | 41 | 32 | 4 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.05e-06 | 45 | 32 | 4 | MM15694 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 3.80e-06 | 14 | 32 | 3 | M39328 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 5.07e-06 | 51 | 32 | 4 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 5.48e-06 | 52 | 32 | 4 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 6.88e-06 | 55 | 32 | 4 | M14933 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.26e-05 | 64 | 32 | 4 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.80e-05 | 70 | 32 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.02e-05 | 72 | 32 | 4 | M9257 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 2.24e-05 | 153 | 32 | 5 | MM15844 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 9.58e-05 | 107 | 32 | 4 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.03e-04 | 109 | 32 | 4 | M18788 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.24e-04 | 219 | 32 | 5 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.26e-04 | 220 | 32 | 5 | M10320 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.32e-04 | 44 | 32 | 3 | M45014 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 1.41e-04 | 45 | 32 | 3 | M39615 | |
| Pathway | REACTOME_RIBAVIRIN_ADME | 2.71e-04 | 11 | 32 | 2 | M46429 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 3.09e-04 | 145 | 32 | 4 | M45512 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 3.25e-04 | 12 | 32 | 2 | M39611 | |
| Pathway | REACTOME_RIBAVIRIN_ADME | 3.25e-04 | 12 | 32 | 2 | MM16638 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 5.15e-04 | 15 | 32 | 2 | MM1387 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 6.65e-04 | 17 | 32 | 2 | M5940 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 7.44e-04 | 183 | 32 | 4 | M39588 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 1.02e-03 | 21 | 32 | 2 | M39631 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 1.23e-03 | 23 | 32 | 2 | M45013 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 1.34e-03 | 24 | 32 | 2 | M46445 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 1.69e-03 | 27 | 32 | 2 | MM15693 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.95e-03 | 29 | 32 | 2 | M45015 | |
| Pathway | REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | 1.95e-03 | 29 | 32 | 2 | M27408 | |
| Pathway | REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | 1.95e-03 | 29 | 32 | 2 | MM15158 | |
| Pathway | PID_CDC42_REG_PATHWAY | 2.09e-03 | 30 | 32 | 2 | M83 | |
| Pathway | WP_NRF2_PATHWAY | 3.93e-03 | 141 | 32 | 3 | M39454 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 5.03e-03 | 154 | 32 | 3 | M27832 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 5.31e-03 | 314 | 32 | 4 | M39428 | |
| Pubmed | 2.49e-11 | 6 | 41 | 4 | 20297805 | ||
| Pubmed | 2.49e-11 | 6 | 41 | 4 | 32527940 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 5.80e-11 | 7 | 41 | 4 | 8467709 | |
| Pubmed | 5.80e-11 | 7 | 41 | 4 | 8464825 | ||
| Pubmed | 5.80e-11 | 7 | 41 | 4 | 27514509 | ||
| Pubmed | 1.16e-10 | 8 | 41 | 4 | 17179145 | ||
| Pubmed | 1.16e-10 | 8 | 41 | 4 | 20610558 | ||
| Pubmed | 1.16e-10 | 8 | 41 | 4 | 18052087 | ||
| Pubmed | 2.08e-10 | 9 | 41 | 4 | 22511988 | ||
| Pubmed | 3.47e-10 | 10 | 41 | 4 | 23642732 | ||
| Pubmed | 3.47e-10 | 10 | 41 | 4 | 11465080 | ||
| Pubmed | 3.47e-10 | 10 | 41 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 3.47e-10 | 10 | 41 | 4 | 22558097 | |
| Pubmed | 8.17e-10 | 12 | 41 | 4 | 19419973 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 8.17e-10 | 12 | 41 | 4 | 20308471 | |
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 8.17e-10 | 12 | 41 | 4 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 1.18e-09 | 13 | 41 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 1.18e-09 | 13 | 41 | 4 | 25246029 | |
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 8270257 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 29519853 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 12847094 | ||
| Pubmed | 1.65e-09 | 14 | 41 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.65e-09 | 14 | 41 | 4 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.65e-09 | 14 | 41 | 4 | 14672974 | |
| Pubmed | 1.65e-09 | 14 | 41 | 4 | 9295054 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 2.99e-09 | 16 | 41 | 4 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 3.91e-09 | 17 | 41 | 4 | 20639394 | |
| Pubmed | 5.02e-09 | 18 | 41 | 4 | 20056724 | ||
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 17558305 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 6.36e-09 | 19 | 41 | 4 | 23281178 | |
| Pubmed | 1.52e-08 | 5 | 41 | 3 | 20565459 | ||
| Pubmed | 1.52e-08 | 5 | 41 | 3 | 15057901 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 1.74e-08 | 24 | 41 | 4 | 24625756 | |
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 1.27e-07 | 9 | 41 | 3 | 20732626 | |
| Pubmed | 2.49e-07 | 11 | 41 | 3 | 18695635 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 6.27e-07 | 57 | 41 | 4 | 21886157 | |
| Pubmed | 1.14e-06 | 66 | 41 | 4 | 19898482 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 11677206 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 22031623 | ||
| Pubmed | Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. | 1.36e-06 | 2 | 41 | 2 | 2509941 | |
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 1.36e-06 | 2 | 41 | 2 | 10497143 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 18568343 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 1.36e-06 | 2 | 41 | 2 | 17603215 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 15709193 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12944498 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 25547628 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12200143 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 21085602 | ||
| Pubmed | The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis. | 1.36e-06 | 2 | 41 | 2 | 32392889 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 9647757 | ||
| Pubmed | Long-chain fatty acyl coenzyme A inhibits NME1/2 and regulates cancer metastasis. | 1.36e-06 | 2 | 41 | 2 | 35259022 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 17529886 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 7488060 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 8245015 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12007505 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 20089735 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12972261 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 11901093 | ||
| Pubmed | Organization and expression of mouse nm23-M1 gene. Comparison with nm23-M2 expression. | 4.06e-06 | 3 | 41 | 2 | 10452942 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 32860079 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 19225446 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 25748386 | ||
| Pubmed | Nm23/NDP kinases in human male germ cells: role in spermiogenesis and sperm motility? | 4.06e-06 | 3 | 41 | 2 | 14499630 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 23789755 | ||
| Pubmed | Novel roles of NM23 proteins in skin homeostasis, repair and disease. | 4.06e-06 | 3 | 41 | 2 | 16862176 | |
| Pubmed | Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis. | 4.06e-06 | 3 | 41 | 2 | 11042679 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 33024267 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 19364970 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 19805292 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 17406868 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 8392752 | ||
| Pubmed | Disrupted IRF6-NME1/2 Complexes as a Cause of Cleft Lip/Palate. | 4.06e-06 | 3 | 41 | 2 | 28767310 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 22080566 | ||
| Pubmed | Association of nucleoside diphosphate kinase nm23-H2 with human telomeres. | 4.06e-06 | 3 | 41 | 2 | 9480811 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 30411342 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 16636344 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 15530864 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 4.06e-06 | 3 | 41 | 2 | 20007669 | |
| Pubmed | nm23 regulates decidualization through the PI3K-Akt-mTOR signaling pathways in mice and humans. | 4.06e-06 | 3 | 41 | 2 | 27604954 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 23721685 | ||
| Pubmed | Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. | 4.06e-06 | 3 | 41 | 2 | 15928304 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 1851158 | ||
| Pubmed | Substrate specificity of human nucleoside-diphosphate kinase revealed by transient kinetic analysis. | 4.06e-06 | 3 | 41 | 2 | 9488696 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 19244109 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 11277919 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 8543593 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 19996319 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 25010650 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 26247833 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 16397224 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 19619546 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 9881672 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 22421058 | ||
| Pubmed | NM23 proteins: innocent bystanders or local energy boosters for CFTR? | 4.06e-06 | 3 | 41 | 2 | 29251738 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 17339869 | ||
| Pubmed | The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. | 4.06e-06 | 3 | 41 | 2 | 11960382 | |
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 4.06e-06 | 3 | 41 | 2 | 24453052 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 8600152 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 26299592 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 18946804 | ||
| Interaction | UGT1A7 interactions | 1.05e-07 | 57 | 41 | 5 | int:UGT1A7 | |
| Interaction | UGT1A9 interactions | 2.20e-06 | 13 | 41 | 3 | int:UGT1A9 | |
| Interaction | UGT1A8 interactions | 1.21e-05 | 3 | 41 | 2 | int:UGT1A8 | |
| Interaction | NME1-NME2 interactions | 3.94e-05 | 94 | 41 | 4 | int:NME1-NME2 | |
| Interaction | UGT1A10 interactions | 4.09e-05 | 33 | 41 | 3 | int:UGT1A10 | |
| Cytoband | 2q37 | 1.69e-08 | 31 | 41 | 4 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 5.02e-05 | 226 | 41 | 4 | chr2q37 | |
| Cytoband | 17q21.3 | 9.26e-05 | 16 | 41 | 2 | 17q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 5.12e-04 | 415 | 41 | 4 | chr12q24 | |
| Cytoband | 12q24.31 | 2.35e-03 | 80 | 41 | 2 | 12q24.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 7.90e-03 | 149 | 41 | 2 | chr2p23 | |
| GeneFamily | UDP glucuronosyltransferases | 1.61e-07 | 32 | 28 | 4 | 363 | |
| GeneFamily | NME/NM23 family | 8.27e-05 | 9 | 28 | 2 | 961 | |
| GeneFamily | FKBP prolyl isomerases | 3.48e-04 | 18 | 28 | 2 | 910 | |
| GeneFamily | Solute carriers | 3.03e-03 | 395 | 28 | 4 | 752 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR | 4.14e-06 | 154 | 41 | 5 | MM1313 | |
| Drug | naringenin chalcone | 4.52e-11 | 5 | 41 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 4.52e-11 | 5 | 41 | 4 | ctd:C032186 | |
| Drug | Woodward's reagent K | 1.35e-10 | 43 | 41 | 6 | CID000077804 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 1.35e-10 | 6 | 41 | 4 | ctd:C543211 | |
| Drug | alloin | 1.35e-10 | 6 | 41 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 1.35e-10 | 6 | 41 | 4 | ctd:C107497 | |
| Drug | 2',4'-dihydroxychalcone | 3.15e-10 | 7 | 41 | 4 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 6.30e-10 | 8 | 41 | 4 | ctd:C034890 | |
| Drug | AC1MRQNQ | 1.13e-09 | 9 | 41 | 4 | CID003522271 | |
| Drug | DHPASiU | 1.13e-09 | 9 | 41 | 4 | CID000197602 | |
| Drug | Chebi:32663 | 1.13e-09 | 9 | 41 | 4 | CID005460873 | |
| Drug | 3-iodophenol | 1.13e-09 | 9 | 41 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 1.13e-09 | 9 | 41 | 4 | CID000186631 | |
| Drug | 2,6-dihydroxyanthraquinone | 1.89e-09 | 10 | 41 | 4 | ctd:C034889 | |
| Drug | 4-nitrophenyl)imidazole | 2.96e-09 | 11 | 41 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 2.96e-09 | 11 | 41 | 4 | CID006442661 | |
| Drug | N-OH-DABZ | 4.43e-09 | 12 | 41 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 4.43e-09 | 12 | 41 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 4.43e-09 | 12 | 41 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 4.43e-09 | 12 | 41 | 4 | CID000037247 | |
| Drug | 7,7,7-triphenylheptanoic acid | 4.43e-09 | 12 | 41 | 4 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 4.43e-09 | 12 | 41 | 4 | CID000160090 | |
| Drug | 2-hydroxyestrone | 6.39e-09 | 13 | 41 | 4 | ctd:C024980 | |
| Drug | tritanol | 6.39e-09 | 13 | 41 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 6.39e-09 | 13 | 41 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 6.39e-09 | 13 | 41 | 4 | CID000000411 | |
| Drug | alizarin | 6.39e-09 | 13 | 41 | 4 | ctd:C010078 | |
| Drug | propranolol glucuronide | 8.94e-09 | 14 | 41 | 4 | CID000119515 | |
| Drug | PCB-61 | 8.94e-09 | 14 | 41 | 4 | CID000036401 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.22e-08 | 15 | 41 | 4 | CID000040469 | |
| Drug | coumarin-3-carboxylic acid | 1.22e-08 | 15 | 41 | 4 | CID000010752 | |
| Drug | bergamottin | 1.22e-08 | 15 | 41 | 4 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 1.22e-08 | 15 | 41 | 4 | CID000543743 | |
| Drug | afloqualone | 1.22e-08 | 15 | 41 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 1.22e-08 | 15 | 41 | 4 | CID000114775 | |
| Drug | quercetin-3,4'-diglucoside | 1.62e-08 | 16 | 41 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 1.62e-08 | 16 | 41 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 1.62e-08 | 16 | 41 | 4 | CID005497144 | |
| Drug | 7,3'-dihydroxy-4'-methoxyisoflavone | 1.91e-08 | 46 | 41 | 5 | ctd:C121707 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 2.12e-08 | 17 | 41 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 2.12e-08 | 17 | 41 | 4 | CID000037766 | |
| Drug | 2-vanillin | 2.17e-08 | 4 | 41 | 3 | ctd:C060843 | |
| Drug | hydratropic acid | 2.17e-08 | 4 | 41 | 3 | ctd:C013025 | |
| Drug | diphenylacetic acid | 2.17e-08 | 4 | 41 | 3 | ctd:C037760 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 2.72e-08 | 18 | 41 | 4 | CID000152226 | |
| Drug | Br 2 | 2.72e-08 | 18 | 41 | 4 | CID003060900 | |
| Drug | SureCN12722713 | 2.72e-08 | 18 | 41 | 4 | CID005488034 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 2.72e-08 | 18 | 41 | 4 | CID000036614 | |
| Drug | ApApG | 2.72e-08 | 18 | 41 | 4 | CID003081975 | |
| Drug | C1 11-32 | 2.72e-08 | 18 | 41 | 4 | CID000443077 | |
| Drug | C11131 | 2.72e-08 | 18 | 41 | 4 | CID000443076 | |
| Drug | almokalant | 3.44e-08 | 19 | 41 | 4 | CID003033962 | |
| Drug | 9-OH-risperidone | 3.44e-08 | 19 | 41 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 3.44e-08 | 19 | 41 | 4 | CID000091433 | |
| Drug | bropirimine | 3.59e-08 | 52 | 41 | 5 | CID000065457 | |
| Drug | tectochrysin | 4.29e-08 | 20 | 41 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 4.29e-08 | 20 | 41 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 4.29e-08 | 20 | 41 | 4 | CID000116545 | |
| Drug | entacapone | 4.29e-08 | 20 | 41 | 4 | ctd:C071192 | |
| Drug | estriol-16-glucuronide | 5.30e-08 | 21 | 41 | 4 | CID000122281 | |
| Drug | dulcin | 5.30e-08 | 21 | 41 | 4 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 5.30e-08 | 21 | 41 | 4 | CID000069186 | |
| Drug | isovaleric acid | 5.41e-08 | 5 | 41 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 5.41e-08 | 5 | 41 | 3 | ctd:C012776 | |
| Drug | amonafide | 6.46e-08 | 22 | 41 | 4 | CID000050515 | |
| Drug | plumbagin | 6.46e-08 | 22 | 41 | 4 | ctd:C014758 | |
| Drug | N-methylpiperazine | 6.46e-08 | 22 | 41 | 4 | CID000053167 | |
| Drug | amidoxime | 7.82e-08 | 23 | 41 | 4 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 7.82e-08 | 23 | 41 | 4 | CID000066651 | |
| Drug | phenanthridine | 7.82e-08 | 23 | 41 | 4 | CID000009189 | |
| Drug | AS-3201 | 9.37e-08 | 24 | 41 | 4 | CID000153948 | |
| Drug | 3-phenylpropionic acid | 1.08e-07 | 6 | 41 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 1.08e-07 | 6 | 41 | 3 | ctd:D007216 | |
| Drug | 5-MOP | 1.11e-07 | 25 | 41 | 4 | CID000002355 | |
| Drug | Hymecromone | 1.11e-07 | 25 | 41 | 4 | ctd:D006923 | |
| Drug | AzMC | 1.11e-07 | 25 | 41 | 4 | CID000064986 | |
| Drug | N-acetylbenzidine | 1.11e-07 | 25 | 41 | 4 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 1.11e-07 | 25 | 41 | 4 | CID000006796 | |
| Drug | N-phenylmaleimide | 1.11e-07 | 25 | 41 | 4 | CID000013662 | |
| Drug | Thymol | 1.31e-07 | 26 | 41 | 4 | ctd:D013943 | |
| Drug | Scopoletin | 1.54e-07 | 27 | 41 | 4 | ctd:D012603 | |
| Drug | DiMeIQx | 1.54e-07 | 27 | 41 | 4 | CID000104739 | |
| Drug | licochalcone A | 1.54e-07 | 27 | 41 | 4 | ctd:C070840 | |
| Drug | diflunisal | 1.54e-07 | 27 | 41 | 4 | CID000003059 | |
| Drug | N-hydroxy-4-aminobiphenyl | 1.80e-07 | 28 | 41 | 4 | CID000081261 | |
| Drug | CARMINE | 1.80e-07 | 28 | 41 | 4 | CID000014749 | |
| Drug | erucin | 1.80e-07 | 28 | 41 | 4 | CID000078160 | |
| Drug | H-Ni | 1.80e-07 | 28 | 41 | 4 | CID000445665 | |
| Drug | AC1L1JAL | 2.08e-07 | 29 | 41 | 4 | CID000004954 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 2.08e-07 | 29 | 41 | 4 | CID005375667 | |
| Drug | trans-3'-hydroxycotinine | 2.08e-07 | 29 | 41 | 4 | CID000000414 | |
| Drug | 7-hydroxycoumarin glucuronide | 2.08e-07 | 29 | 41 | 4 | CID000125641 | |
| Drug | iberin | 2.08e-07 | 29 | 41 | 4 | CID000010455 | |
| Drug | 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | 2.08e-07 | 29 | 41 | 4 | ctd:C060533 | |
| Drug | 7-hydroxycoumarin | 2.31e-07 | 75 | 41 | 5 | CID005281426 | |
| Drug | tolcapone | 2.40e-07 | 30 | 41 | 4 | CID004659569 | |
| Drug | paricalcitol | 2.40e-07 | 30 | 41 | 4 | CID005281104 | |
| Drug | AC1L9E0Q | 2.40e-07 | 30 | 41 | 4 | CID000443095 | |
| Drug | dihydroartemisinin | 2.40e-07 | 30 | 41 | 4 | CID000107770 | |
| Drug | 4-ethylphenol | 2.75e-07 | 31 | 41 | 4 | CID000031242 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 1.60e-11 | 5 | 41 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 1.60e-11 | 5 | 41 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 1.60e-11 | 5 | 41 | 4 | EFO_0801853 | |
| Disease | X-21339 measurement | 1.12e-10 | 7 | 41 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 2.24e-10 | 8 | 41 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.24e-10 | 8 | 41 | 4 | EFO_0022118 | |
| Disease | X-24849 measurement | 2.24e-10 | 8 | 41 | 4 | EFO_0800909 | |
| Disease | X-11530 measurement | 2.24e-10 | 8 | 41 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.24e-10 | 8 | 41 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 2.24e-10 | 8 | 41 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 2.24e-10 | 8 | 41 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.24e-10 | 8 | 41 | 4 | EFO_0800692 | |
| Disease | serum N-desmethylclozapine measurement | 2.24e-10 | 8 | 41 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 2.24e-10 | 8 | 41 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.24e-10 | 8 | 41 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.24e-10 | 8 | 41 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 4.02e-10 | 9 | 41 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 4.02e-10 | 9 | 41 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 4.02e-10 | 9 | 41 | 4 | EFO_0004739 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 4.02e-10 | 9 | 41 | 4 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 4.02e-10 | 9 | 41 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 4.02e-10 | 9 | 41 | 4 | EFO_0801036 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 4.02e-10 | 9 | 41 | 4 | EFO_0004570, GO_0009410 | |
| Disease | X-11880 measurement | 4.02e-10 | 9 | 41 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 4.02e-10 | 9 | 41 | 4 | EFO_0020691 | |
| Disease | X-21448 measurement | 6.69e-10 | 10 | 41 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 6.69e-10 | 10 | 41 | 4 | EFO_0802185 | |
| Disease | bilirubin measurement, response to tenofovir | 6.69e-10 | 10 | 41 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | X-23974 measurement | 6.69e-10 | 10 | 41 | 4 | EFO_0800867 | |
| Disease | pregnenetriol sulfate measurement | 1.05e-09 | 11 | 41 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.05e-09 | 11 | 41 | 4 | EFO_0600039 | |
| Disease | insomnia, bilirubin measurement | 1.05e-09 | 11 | 41 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 1.05e-09 | 11 | 41 | 4 | EFO_0800972 | |
| Disease | aldosterone measurement | 1.05e-09 | 11 | 41 | 4 | EFO_0010219 | |
| Disease | X-21796 measurement | 1.05e-09 | 11 | 41 | 4 | EFO_0800825 | |
| Disease | biliverdin measurement | 1.57e-09 | 12 | 41 | 4 | EFO_0021033 | |
| Disease | p-cresol glucuronide measurement | 1.57e-09 | 12 | 41 | 4 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 2.27e-09 | 13 | 41 | 4 | EFO_0802007 | |
| Disease | pregnenetriol disulfate measurement | 2.27e-09 | 13 | 41 | 4 | EFO_0800587 | |
| Disease | blood 4-oxo-retinoic acid measurement | 2.49e-09 | 3 | 41 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 2.49e-09 | 3 | 41 | 3 | EFO_0800043 | |
| Disease | X-21441 measurement | 7.53e-09 | 17 | 41 | 4 | EFO_0800814 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 7.53e-09 | 17 | 41 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 9.68e-09 | 18 | 41 | 4 | EFO_0801382 | |
| Disease | tissue factor measurement | 1.89e-08 | 21 | 41 | 4 | EFO_0010623 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 4.97e-08 | 6 | 41 | 3 | EFO_0800566 | |
| Disease | neuroblastoma, cutaneous melanoma | 6.41e-08 | 28 | 41 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 7.43e-08 | 29 | 41 | 4 | EFO_0010551 | |
| Disease | response to dolutegravir | 8.56e-08 | 30 | 41 | 4 | EFO_0600017 | |
| Disease | vitamin D deficiency | 2.05e-07 | 37 | 41 | 4 | EFO_0003762 | |
| Disease | indoleacetate measurement | 2.97e-07 | 10 | 41 | 3 | EFO_0021015 | |
| Disease | vitamin D measurement, COVID-19 | 6.49e-07 | 49 | 41 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | X-24588 measurement | 7.05e-07 | 13 | 41 | 3 | EFO_0800898 | |
| Disease | urate measurement, spine bone mineral density | 1.29e-06 | 58 | 41 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | thyroxine measurement | 5.44e-06 | 83 | 41 | 4 | EFO_0005130 | |
| Disease | hormone measurement | 5.71e-06 | 84 | 41 | 4 | EFO_0004730 | |
| Disease | cholelithiasis | 6.87e-06 | 88 | 41 | 4 | EFO_0004799 | |
| Disease | gallstones | 1.55e-05 | 108 | 41 | 4 | EFO_0004210 | |
| Disease | teratoma (is_implicated_in) | 1.88e-05 | 5 | 41 | 2 | DOID:3307 (is_implicated_in) | |
| Disease | nucleoside diphosphate kinase B measurement | 3.94e-05 | 7 | 41 | 2 | EFO_0020615 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 5.19e-05 | 147 | 41 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | dodecanedioate measurement | 1.23e-04 | 12 | 41 | 2 | EFO_0021054 | |
| Disease | temporal horn of lateral ventricle volume measurement | 1.39e-04 | 72 | 41 | 3 | EFO_0010333 | |
| Disease | metabolite measurement | 1.03e-03 | 560 | 41 | 5 | EFO_0004725 | |
| Disease | vitamin D measurement | 1.20e-03 | 336 | 41 | 4 | EFO_0004631 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RIEIWVMHEIGGPNV | 221 | Q10588 | |
| VGWGIPAIMVAITVS | 2856 | Q8IZF6 | |
| DVAVIGVPDMTWGQR | 501 | Q4G176 | |
| GVPDMTWGQRVTAVV | 506 | Q4G176 | |
| VIRGWEEGVAQMSVG | 56 | P62942 | |
| PVWETIVCTMREGEI | 71 | O00170 | |
| LGVVWLVAVIVGSPM | 166 | Q96P65 | |
| GAVVTGAVVAAVMWR | 316 | P30511 | |
| GPVVAMVWEGLNVVK | 71 | P22392 | |
| GGWVPLVMDDVKVAT | 271 | P51610 | |
| DVMARGIDIPEVNWV | 326 | Q8NHQ9 | |
| TMQGTWVEPELRGVI | 106 | O14782 | |
| VVPVAVAAWGVGGML | 166 | Q8WUY8 | |
| VMQPDGIAVDWVGRH | 4141 | P98164 | |
| DILEVVGGWPVAMDR | 191 | Q495T6 | |
| IQPGDIVMVKGEWVD | 761 | Q15811 | |
| MIPVSLVVVVVGGWT | 1 | O43462 | |
| IPWQEEMIETGIFGE | 516 | Q15835 | |
| LVVEWMPTRGRTVAG | 211 | A6NK97 | |
| QEVGWGDVPVIAMET | 181 | P20132 | |
| VQDRMSVIWERGVVG | 351 | Q9BPU6 | |
| QVVTMLGPDWLVEVT | 611 | Q6IEE7 | |
| GPVVAMVWEGLNVVK | 71 | P15531 | |
| GPVVAMVWEGLNVVK | 56 | O60361 | |
| PEVKTWGGVVTAAMV | 271 | Q9NVC3 | |
| ISIAWVPIIVEMQGG | 421 | P53794 | |
| WEPVITAMVISSIGG | 381 | Q96JW4 | |
| ATMSEVEWRGRTVPV | 291 | Q9UHB9 | |
| RGHEVVVVMPEVSWQ | 51 | Q9HAW8 | |
| VSWSQVGVEPSIMGI | 281 | Q9BWD1 | |
| RSGAPNVVVVMVDGW | 391 | Q6UXI7 | |
| NVVVVMVDGWPTDKV | 396 | Q6UXI7 | |
| RGHEVVVVMPEVSWQ | 51 | O60656 | |
| VPFGEVSMVRDWLGI | 96 | Q53HV7 | |
| VSMVRDWLGIVGPVL | 101 | Q53HV7 | |
| GIWVMVDPTGFREIV | 31 | Q96SJ8 | |
| DSPVGVREMEIWLSV | 391 | Q8N0Z9 | |
| VGTMAWVRIPVEGEV | 516 | O60294 | |
| CVTAGTPEVWVQVRM | 36 | Q6DKI7 | |
| TKVVAMGVAPWGVVR | 181 | Q8TD43 | |
| RGHEVVVVMPEVSWQ | 51 | Q9HAW7 | |
| GVVRHIQWTPREMEV | 911 | A6NCI4 | |
| RGHEVVVVMPEVSWQ | 51 | Q9HAW9 | |
| MKGIGWVPIDSLEVV | 3391 | P20929 |